Quarterly report · Q2
7776.TEDINET S100RMQI
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥67m | 2023-01-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥126m | 2022-01-01 → 2022-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥75m | 2022-01-01 → 2022-06-30 | Standalone | Net sales |
| Operating income | −¥359m | 2023-01-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | −¥349m | 2022-01-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | −¥367m | 2023-01-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥754m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥353m | 2022-01-01 → 2022-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥363m | 2023-01-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥355m | 2022-01-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | −¥364m | 2023-01-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | −¥760m | 2022-01-01 → 2022-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥357m | 2022-01-01 → 2022-06-30 | Standalone | Profit loss |
| Total assets | ¥2.0bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.7bn | at 2022-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥363m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥366m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.7bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2023-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥847m | at 2021-12-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥348m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥718m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥269m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥18m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥62m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥848m | 2023-01-01 → 2023-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥882m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥606m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-13.29 | 2023-01-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.49 | 2023-04-01 → 2023-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.31 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.54 | 2022-01-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.75 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.1% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.1% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 28,385,419 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,422,619 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 22,159,419 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥96m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥5m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥5m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥236m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥62m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥62m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥28m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥67m |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥67m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | −¥263m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥100m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥208m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥70m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥70m |
| jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥41m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥75m |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥75m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | −¥248m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 443
| Item | Context | Value | Unit |
|---|---|---|---|
| Extraordinary loss | CurrentYTDDuration_NonConsolidatedMember | 13172000 | JPY |
| Income before income taxes | Prior1YTDDuration_NonConsolidatedMember | -355225000 | JPY |
| Income before income taxes | CurrentYTDDuration_NonConsolidatedMember | -363483000 | JPY |
| Income taxes current | Prior1YTDDuration_NonConsolidatedMember | 1900000 | JPY |
| Income taxes current | CurrentYTDDuration_NonConsolidatedMember | 475000 | JPY |
| Income taxes | Prior1YTDDuration_NonConsolidatedMember | 1900000 | JPY |
| Income taxes | CurrentYTDDuration_NonConsolidatedMember | 475000 | JPY |
| Profit loss | Prior1YTDDuration_NonConsolidatedMember | -357125000 | JPY |
| Profit loss | CurrentYTDDuration_NonConsolidatedMember | -363958000 | JPY |
| Income before income taxes | Prior1YTDDuration_NonConsolidatedMember | -355225000 | JPY |
| Income before income taxes | CurrentYTDDuration_NonConsolidatedMember | -363483000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration_NonConsolidatedMember | 3932000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration_NonConsolidatedMember | 3995000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration_NonConsolidatedMember | 2445000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration_NonConsolidatedMember | 13172000 | JPY |
| Interest income ope cf | Prior1YTDDuration_NonConsolidatedMember | -5000 | JPY |
| Interest income ope cf | CurrentYTDDuration_NonConsolidatedMember | -5000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration_NonConsolidatedMember | 418000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration_NonConsolidatedMember | 388000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration_NonConsolidatedMember | 798000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Stock issuance cost prior ope cf | Prior1YTDDuration_NonConsolidatedMember | 5705000 | JPY |
| Stock issuance cost prior ope cf | CurrentYTDDuration_NonConsolidatedMember | 8476000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Gain on reversal of subscription rights to shares ope cf | CurrentYTDDuration_NonConsolidatedMember | -609000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYTDDuration_NonConsolidatedMember | -15759000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration_NonConsolidatedMember | 2113000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration_NonConsolidatedMember | 2603000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration_NonConsolidatedMember | -20689000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration_NonConsolidatedMember | -2753000 | JPY |
| Decrease increase in other current assets ope cf | Prior1YTDDuration_NonConsolidatedMember | 49394000 | JPY |
| Decrease increase in other current assets ope cf | CurrentYTDDuration_NonConsolidatedMember | 9013000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration_NonConsolidatedMember | 5320000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration_NonConsolidatedMember | 5675000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration_NonConsolidatedMember | -42814000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration_NonConsolidatedMember | 22203000 | JPY |
| Increase decrease in advances received ope cf | Prior1YTDDuration_NonConsolidatedMember | 30772000 | JPY |
| Increase decrease in advances received ope cf | CurrentYTDDuration_NonConsolidatedMember | -39013000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration_NonConsolidatedMember | -509000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration_NonConsolidatedMember | 413000 | JPY |
| Increase decrease in other current liabilities ope cf | Prior1YTDDuration_NonConsolidatedMember | 53225000 | JPY |
| Increase decrease in other current liabilities ope cf | CurrentYTDDuration_NonConsolidatedMember | 8629000 | JPY |
| Subtotal ope cf | Prior1YTDDuration_NonConsolidatedMember | -265117000 | JPY |
| Subtotal ope cf | CurrentYTDDuration_NonConsolidatedMember | -347054000 | JPY |
| Interest income received ope cf | Prior1YTDDuration_NonConsolidatedMember | 4000 | JPY |
| Interest income received ope cf | CurrentYTDDuration_NonConsolidatedMember | 4000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration_NonConsolidatedMember | -480000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration_NonConsolidatedMember | -388000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration_NonConsolidatedMember | -3798000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |